The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Meridian Bioscience Inc

Nasdaq: VIVO
Last

(U.S.) $17.45

Today's change+0.10 +0.58%
Updated December 2 4:00 PM EST. Delayed by at least 15 minutes.
 

Meridian Bioscience Inc

Nasdaq: VIVO
Last

(U.S.) $17.45

Today's change+0.10 +0.58%
Updated December 2 4:00 PM EST. Delayed by at least 15 minutes.

Meridian Bioscience Inc up (U.S.)$0.10

Meridian Bioscience Inc closed up Friday by (U.S.)$0.10 or 0.58% to (U.S.)$17.45. Over the last five days, shares have gained 1.16%, but are down 14.96% for the last year to date. Shares have underperformed the S&P 500 by 17.23% during the last year.

Key company metrics

  • Open(U.S.) $17.40
  • Previous close(U.S.) $17.35
  • High(U.S.) $17.65
  • Low(U.S.) $17.28
  • Bid / Ask(U.S.) $15.65 / (U.S.) $20.55
  • YTD % change-14.96%
  • Volume379,272
  • Average volume (10-day)295,000
  • Average volume (1-month)324,579
  • Average volume (3-month)239,375
  • 52-week range(U.S.) $15.75 to (U.S.) $21.49
  • Beta0.98
  • Trailing P/E22.96×
  • P/E 1 year forward21.37×
  • Forward PEG1.34×
  • Indicated annual dividend(U.S.) $0.80
  • Dividend yield4.58%
  • Trailing EPS(U.S.) $0.76
Updated December 2 4:00 PM EST. Delayed by at least 15 minutes.
S&P TSX0.17%Sector:HealthcareIndustry:Medical Equipment, Supplies & Distribution
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2016Q3/2016Q2/2016Q1/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015
Revenue47515147
Total other revenue--------
Total revenue47515147
Gross profit30333432
Total cost of revenue17181816
Total operating expense38373634
Selling / general / administrative16161515
Research & development4433
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)10----
Other operating expenses, total--------
Operating income9141514
Interest income (expense), net non-operating--00--
Gain (loss) on sale of assets--------
Other--------
Income before tax9131514
Income after tax5999
Income tax, total3565
Net income5999
Total adjustments to net income--------
Net income before extra. items5999
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items5999
Inc. avail. to common incl. extra. items5999
Diluted net income5999
Dilution adjustment----0--
Diluted weighted average shares42424242
Diluted EPS excluding extraordinary itemsvalue per share0.130.210.210.21
Dividends per sharevalue per share0.200.200.200.20
Diluted normalized EPSvalue per share0.140.210.210.21